Adenosine receptor: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Adenosine Receptor == | == Adenosine Receptor == | ||
[[File:10_caffeine_knowing-neurons.jpg|thumb|right|Caffeine, a known antagonist | [[File:10_caffeine_knowing-neurons.jpg|thumb|right|Caffeine, a known adenosine receptor antagonist.]] | ||
Adenosine receptors are a class of [[purinergic receptors]] that are activated by the endogenous nucleoside [[adenosine]]. These receptors are involved in a wide range of physiological processes, including [[cardiovascular]] function, [[neurotransmission]], and [[immune response]]. There are four known subtypes of adenosine receptors: A1, A2A, A2B, and A3, each with distinct tissue distributions and functions. | Adenosine receptors are a class of [[purinergic receptors]] that are activated by the endogenous nucleoside [[adenosine]]. These receptors are involved in a wide range of physiological processes, including [[cardiovascular]] function, [[neurotransmission]], and [[immune response]]. There are four known subtypes of adenosine receptors: A1, A2A, A2B, and A3, each with distinct tissue distributions and functions. | ||
== Subtypes == | == Subtypes of Adenosine Receptors == | ||
=== A1 Receptor === | === A1 Receptor === | ||
The A1 receptor is widely expressed in the [[central nervous system]] and the [[heart]]. It plays a crucial role in reducing [[neurotransmitter]] release and has a protective effect on the heart by | The A1 receptor is widely expressed in the [[central nervous system]] and the [[heart]]. It plays a crucial role in reducing [[neurotransmitter]] release and has a protective effect on the heart by decreasing [[heart rate]] and [[myocardial oxygen consumption]]. | ||
=== A2A Receptor === | === A2A Receptor === | ||
| Line 14: | Line 14: | ||
=== A2B Receptor === | === A2B Receptor === | ||
The A2B receptor is expressed in various tissues, including the [[lung]] and [[ | The A2B receptor is expressed in various tissues, including the [[intestine]], [[lung]], and [[vascular smooth muscle]]. It is involved in [[inflammatory responses]] and [[bronchodilation]]. | ||
=== A3 Receptor === | === A3 Receptor === | ||
The A3 receptor is | The A3 receptor is found in the [[liver]], [[lung]], and [[immune cells]]. It has been implicated in [[anti-inflammatory]] and [[anti-cancer]] effects. | ||
== Mechanism of Action == | == Mechanism of Action == | ||
Adenosine receptors are [[G protein-coupled receptors]] (GPCRs) that mediate their effects through the activation of intracellular signaling pathways. Upon binding of adenosine, these receptors can activate or inhibit [[adenylate cyclase]], leading to changes in [[cyclic AMP]] levels and subsequent cellular responses. | Adenosine receptors are [[G protein-coupled receptors]] (GPCRs) that mediate their effects through the activation of intracellular signaling pathways. Upon binding of adenosine, these receptors can activate or inhibit [[adenylate cyclase]], leading to changes in [[cyclic AMP]] levels and subsequent cellular responses. | ||
== | == Pharmacological Modulation == | ||
[[File:10_caffeine_knowing-neurons.jpg|thumb|left|Caffeine acts as an antagonist at adenosine receptors.]] | |||
== Clinical | Adenosine receptors are targets for various pharmacological agents. [[Caffeine]], a widely consumed [[stimulant]], acts as a non-selective antagonist of adenosine receptors, particularly the A1 and A2A subtypes. This antagonism leads to increased [[alertness]] and [[wakefulness]]. | ||
Adenosine receptors are | |||
== Clinical Implications == | |||
Adenosine receptors are involved in several clinical conditions. For example, A1 receptor agonists are being explored for their potential in treating [[cardiac arrhythmias]], while A2A receptor antagonists are being investigated for their role in [[Parkinson's disease]] and [[cancer]] therapy. | |||
== Related Pages == | == Related Pages == | ||
| Line 33: | Line 35: | ||
* [[Neurotransmitter]] | * [[Neurotransmitter]] | ||
* [[Cardiovascular system]] | * [[Cardiovascular system]] | ||
{{Receptor}} | |||
[[Category:Receptors]] | [[Category:Receptors]] | ||
[[Category:Neuroscience]] | [[Category:Neuroscience]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 16:29, 16 February 2025
Adenosine Receptor[edit]
Adenosine receptors are a class of purinergic receptors that are activated by the endogenous nucleoside adenosine. These receptors are involved in a wide range of physiological processes, including cardiovascular function, neurotransmission, and immune response. There are four known subtypes of adenosine receptors: A1, A2A, A2B, and A3, each with distinct tissue distributions and functions.
Subtypes of Adenosine Receptors[edit]
A1 Receptor[edit]
The A1 receptor is widely expressed in the central nervous system and the heart. It plays a crucial role in reducing neurotransmitter release and has a protective effect on the heart by decreasing heart rate and myocardial oxygen consumption.
A2A Receptor[edit]
The A2A receptor is primarily found in the brain, particularly in the striatum, and is involved in the regulation of dopamine signaling. It also plays a role in vasodilation and immune modulation.
A2B Receptor[edit]
The A2B receptor is expressed in various tissues, including the intestine, lung, and vascular smooth muscle. It is involved in inflammatory responses and bronchodilation.
A3 Receptor[edit]
The A3 receptor is found in the liver, lung, and immune cells. It has been implicated in anti-inflammatory and anti-cancer effects.
Mechanism of Action[edit]
Adenosine receptors are G protein-coupled receptors (GPCRs) that mediate their effects through the activation of intracellular signaling pathways. Upon binding of adenosine, these receptors can activate or inhibit adenylate cyclase, leading to changes in cyclic AMP levels and subsequent cellular responses.
Pharmacological Modulation[edit]
Adenosine receptors are targets for various pharmacological agents. Caffeine, a widely consumed stimulant, acts as a non-selective antagonist of adenosine receptors, particularly the A1 and A2A subtypes. This antagonism leads to increased alertness and wakefulness.
Clinical Implications[edit]
Adenosine receptors are involved in several clinical conditions. For example, A1 receptor agonists are being explored for their potential in treating cardiac arrhythmias, while A2A receptor antagonists are being investigated for their role in Parkinson's disease and cancer therapy.
Related Pages[edit]
| Receptors | ||||||||
|---|---|---|---|---|---|---|---|---|
This receptor related article is a stub.
|
